NCT03329599: Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment
- State
- Completed
- Phase
- Phase 2
- People
- 148 taking part
- Started
- 14 Feb 2019
- Primary completion
- 1 Dec 2021
- Arms
- Polypill
- Results
- Posted on the registry
- 6 Nov 2017: Trial registered
- 14 Feb 2019: Trial started
- 30 Mar 2022: Trial completed
- 20 Dec 2023: Trial results posted